Timothy Hunter, MD
Internal Medicine · Little River, SCNPI 1861491771
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $673 and has fallen 82.5% since, to $117 in 2025.
Across 26 payments — averaging $68.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$261
- AstraZeneca$247
- Amgen$227
- Merck$184
- Phathom Pharmaceuticals, Inc.$126
- Pfizer$125
- plus $607 from 9 others
What the payments were for
- Food & beverage$1,777100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 4 | $261 |
| AstraZeneca | 3 | $247 |
| Amgen | 2 | $227 |
| Merck | 2 | $184 |
| Phathom Pharmaceuticals, Inc. | 1 | $126 |
| Pfizer | 3 | $125 |
| Idorsia Pharmaceuticals US Inc | 1 | $125 |
| Novo Nordisk | 1 | $111 |
| Stryker | 1 | $103 |
| Lilly USA, LLC | 1 | $98 |
| Nevro Corp. | 1 | $58 |
| Amarin Pharma, Inc. | 3 | $56 |
| Abbott | 1 | $23 |
| Exact Sciences | 1 | $20 |
| Boston Scientific | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,777 in reported general payments places this provider in the 75th percentile of 1,498 internal medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 35 | $264 |
| Olmesartan Medoxomil | 14 | $208 |
| Rosuvastatin Calcium | 18 | $189 |
| Levothyroxine Sodium | 16 | $169 |
| Amlodipine Besylate | 19 | $95 |
| Losartan Potassium | 15 | $94 |
| Lisinopril | 16 | $72 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Little River
- Marc ComianosLittle River$15K
- Jerry BackNorth Charleston$322K
- Jan BasileCharleston$278K
- Mark PurcellGreenville$165K
- John CleekCharleston$136K
- William BunnHilton Head Island$125K
- Zion LammGreenville$118K
- Bruce GrayGreenville$111K
- Leonard AlsfeldCharleston$91K
- Edward Botse-BaidooMyrtle Beach$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.